Can Mert
Schriesheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-world outcomes of tumour necrosis factor inhibitor (TNFi) cyclers versus mechanism-of-action switchers among ulcerative colitis patients who failed first-line TNFi.
Journal: BMC gastroenterology
Published: April 04, 2025
Dose Escalation Patterns and Associated Costs of Advanced Therapies for Ulcerative Colitis in France and the United Kingdom: A Retrospective Database Analysis.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: September 10, 2024
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO).
Journal: The Journal of dermatological treatment
Published: May 26, 2024
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies.
Journal: Dermatology and therapy
Published: January 24, 2024
Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO).
Journal: Frontiers in medicine
Published: March 13, 2023
Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis.
Journal: Dermatology and therapy
Published: December 19, 2022
Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey.
Journal: Acta dermato-venereologica
Published: December 08, 2022
Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: October 20, 2022
The Value of Indirect Comparisons of Systemic Biologics for Psoriasis: Interpretation of Efficacy Findings.
Journal: Dermatology and therapy
Published: May 11, 2022
Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain.
Journal: Actas dermo-sifiliograficas
Published: January 26, 2022
Ixekizumab and ustekinumab in psoriasis: post-hoc comparison of onset and duration of treatment response.
Journal: The Journal of dermatological treatment
Published: June 13, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026